4-139547024-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_030648.4(SETD7):c.66G>A(p.Pro22=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00233 in 1,614,016 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 41 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 46 hom. )
Consequence
SETD7
NM_030648.4 synonymous
NM_030648.4 synonymous
Scores
1
10
Clinical Significance
Conservation
PhyloP100: -4.05
Genes affected
SETD7 (HGNC:30412): (SET domain containing 7, histone lysine methyltransferase) Enables histone-lysine N-methyltransferase activity and p53 binding activity. Involved in peptidyl-lysine dimethylation and peptidyl-lysine monomethylation. Acts upstream of or within cellular response to DNA damage stimulus and heterochromatin organization. Located in chromosome and nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.001744777).
BP6
Variant 4-139547024-C-T is Benign according to our data. Variant chr4-139547024-C-T is described in ClinVar as [Benign]. Clinvar id is 786048.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.05 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.012 (1831/152150) while in subpopulation AFR AF= 0.0419 (1741/41510). AF 95% confidence interval is 0.0403. There are 41 homozygotes in gnomad4. There are 835 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1831 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SETD7 | NM_030648.4 | c.66G>A | p.Pro22= | synonymous_variant | 2/8 | ENST00000274031.8 | |
SETD7 | NM_001306199.2 | c.66G>A | p.Pro22= | synonymous_variant | 2/8 | ||
SETD7 | NM_001306200.2 | c.66G>A | p.Pro22= | synonymous_variant | 2/3 | ||
SETD7 | NR_131339.2 | n.249G>A | non_coding_transcript_exon_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SETD7 | ENST00000274031.8 | c.66G>A | p.Pro22= | synonymous_variant | 2/8 | 1 | NM_030648.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0120 AC: 1828AN: 152032Hom.: 41 Cov.: 32
GnomAD3 genomes
AF:
AC:
1828
AN:
152032
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00329 AC: 827AN: 251420Hom.: 14 AF XY: 0.00233 AC XY: 316AN XY: 135888
GnomAD3 exomes
AF:
AC:
827
AN:
251420
Hom.:
AF XY:
AC XY:
316
AN XY:
135888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00132 AC: 1927AN: 1461866Hom.: 46 Cov.: 31 AF XY: 0.00115 AC XY: 833AN XY: 727234
GnomAD4 exome
AF:
AC:
1927
AN:
1461866
Hom.:
Cov.:
31
AF XY:
AC XY:
833
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0120 AC: 1831AN: 152150Hom.: 41 Cov.: 32 AF XY: 0.0112 AC XY: 835AN XY: 74384
GnomAD4 genome
AF:
AC:
1831
AN:
152150
Hom.:
Cov.:
32
AF XY:
AC XY:
835
AN XY:
74384
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
178
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
468
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D;N
PROVEAN
Pathogenic
D
REVEL
Benign
Vest4
MVP
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at